This post is from a suggested group
Digital Therapeutics on Prescription: Germany's Adoption of Mental Health Apps
Germany is pioneering the use of Digital Health Applications (DiGA), allowing mental health apps to be prescribed and reimbursed by statutory health insurance after a rigorous evaluation by the BfArM. This regulatory fast-track provides manufacturers a 12-month trial phase to enter the market, significantly speeding up the access to innovative mental well-being tools.
The core requirement for DiGA listing is demonstrating a verifiable positive care effect, necessitating clinical evidence often gathered through trials, which ensures therapeutic quality and patient benefit. This system fosters trust and integration of digital solutions into mainstream therapy, offering accessible support for conditions like depression and anxiety.